疣状癌(Verrucous Carcinoma):世界の治験レビュー(2015年上半期版)

◆英語タイトル:Verrucous Carcinoma Global Clinical Trials Review, H1, 2015
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2624CTIDB
◆発行日:2015年3月27日
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[疣状癌(Verrucous Carcinoma):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせはこちら
当調査レポートでは、世界における疣状癌(Verrucous Carcinoma) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 疣状癌(Verrucous Carcinoma)
  - 当レポートの概要
・疣状癌(Verrucous Carcinoma):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
*** レポート概要(サマリー)***

Verrucous Carcinoma Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Verrucous Carcinoma Global Clinical Trials Review, H1, 2015″ provides data on the Verrucous Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Verrucous Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Verrucous Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Verrucous Carcinoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Verrucous Carcinoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Verrucous Carcinoma to Oncology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Verrucous Carcinoma 21
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
MatrixPharm 27
Clinical Trial Overview of MatrixPharm 27
Clinical Trial Overview of Top Institutes / Government 28
National Cancer Institute 28
Clinical Trial Overview of National Cancer Institute 28
Roswell Park Cancer Institute 31
Clinical Trial Overview of Roswell Park Cancer Institute 31
Fox Chase Cancer Center 32
Clinical Trial Overview of Fox Chase Cancer Center 32
Ohio State University Comprehensive Cancer Center 33
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 33
Radiation Therapy Oncology Group 34
Clinical Trial Overview of Radiation Therapy Oncology Group 34
University of Chicago 35
Clinical Trial Overview of University of Chicago 35
Wake Forest University 36
Clinical Trial Overview of Wake Forest University 36
Abramson Cancer Center 37
Clinical Trial Overview of Abramson Cancer Center 37
AIDS Malignancy Clinical Trials Consortium 38
Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium 38
Case Comprehensive Cancer Center 39
Clinical Trial Overview of Case Comprehensive Cancer Center 39
Five Key Clinical Profiles 40
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Region, 2015* 6
Verrucous Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Verrucous Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Verrucous Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Verrucous Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11
Verrucous Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 12
Proportion of Verrucous Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Verrucous Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Verrucous Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Verrucous Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2015* 21
Verrucous Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 21
Verrucous Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2015* 22
Verrucous Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Verrucous Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24
Verrucous Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25
Verrucous Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MatrixPharm, 2015* 27
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 28
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015* 31
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 32
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2015* 33
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2015* 34
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 35
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2015* 36
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2015* 37
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Malignancy Clinical Trials Consortium, 2015* 38
Verrucous Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 39

List of Figures
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Verrucous Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Verrucous Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Verrucous Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Verrucous Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 11
Proportion of Verrucous Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2015* 13
Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Verrucous Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Verrucous Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2015* 16
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Verrucous Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Verrucous Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Verrucous Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Verrucous Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23
Verrucous Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24
Verrucous Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 70

*** レポートのキーワード ***

疣状癌(Verrucous Carcinoma)、治験、臨床試験、治験、治療薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2624CTIDB )"疣状癌(Verrucous Carcinoma):世界の治験レビュー(2015年上半期版)" (英文:Verrucous Carcinoma Global Clinical Trials Review, H1, 2015)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。